Shopping Cart 0
Cart Subtotal
AED 0

Five Prime Therapeutics Inc (FPRX) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 1376
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Five Prime Therapeutics Inc (FPRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description - A detailed description of the company's operations and business divisions.

- Corporate strategy - Analyst's summarization of the company's business strategy.

- SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history - Progression of key events associated with the company.

- Major products and services - A list of major products, services and brands of the company.

- Key competitors - A list of key competitors to the company.

- Key employees - A list of the key executives of the company.

- Executive biographies - A brief summary of the executives' employment history.

- Key operational heads - A list of personnel heading key departments/functions.

- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities - A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Five Prime Therapeutics Inc (Five Prime) is a clinical state biopharmaceutical company focusing on the research and development of novel treatments for cancer and inflammatory disorders. The company's developmental pipeline is based on the discovery platform and library of therapeutic proteins. The company's pipeline products include cabiralizumab; Bemarituzumab (FPA144); FPT155; FPA150; and BMS-986258. Five Prime has also developed proprietary protein screening technologies and rapid in vivo protein production system to identify new targets for protein therapeutics. The company has development collaborations with companies such as Bristol-Myers Squibb, GlaxoSmithKline, Zai Lab, Galaxy Biotech, BioWa-Lonza and UCB Pharma. Five Prime is headquartered in South San Francisco, California, the US.

Five Prime Therapeutics Inc Key Recent Developments

Jun 09,2019: Five Prime Therapeutics announces the departure of Dr. Sheila Gujrathi from its board of directors

May 15,2019: Five Prime Therapeutics names Carol Schafer to its board of directors

May 08,2019: Five Prime Therapeutics reports first quarter 2019 results

Mar 26,2019: Study shows Prime Therapeutics NetResults exclusion formulary doesn't lead to more medical use or higher costs

Feb 26,2019: Five Prime Therapeutics announces fourth quarter and full year 2018 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Five Prime Therapeutics Inc - Key Facts

Five Prime Therapeutics Inc - Key Employees

Five Prime Therapeutics Inc - Key Employee Biographies

Five Prime Therapeutics Inc - Major Products and Services

Five Prime Therapeutics Inc - History

Five Prime Therapeutics Inc - Company Statement

Five Prime Therapeutics Inc - Locations And Subsidiaries

Head Office

Section 2 - Company Analysis

Company Overview

Five Prime Therapeutics Inc - Business Description

Five Prime Therapeutics Inc - Corporate Strategy

Five Prime Therapeutics Inc - SWOT Analysis

SWOT Analysis - Overview

Five Prime Therapeutics Inc - Strengths

Five Prime Therapeutics Inc - Weaknesses

Five Prime Therapeutics Inc - Opportunities

Five Prime Therapeutics Inc - Threats

Five Prime Therapeutics Inc - Key Competitors

Section 3 - Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 - Company's Lifesciences Financial Deals and Alliances

Five Prime Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Five Prime Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Five Prime Therapeutics Inc, Recent Deals Summary

Section 5 - Company's Recent Developments

Jun 09, 2019: Five Prime Therapeutics announces the departure of Dr. Sheila Gujrathi from its board of directors

May 15, 2019: Five Prime Therapeutics names Carol Schafer to its board of directors

May 08, 2019: Five Prime Therapeutics reports first quarter 2019 results

Mar 26, 2019: Study shows Prime Therapeutics NetResults exclusion formulary doesn't lead to more medical use or higher costs

Feb 26, 2019: Five Prime Therapeutics announces fourth quarter and full year 2018 financial results

Jan 15, 2019: Five Prime announces restructuring to focus on clinical development and later-stage research priorities

Jan 09, 2019: Adimab provides 2018 update on clinical pipeline

Nov 29, 2018: Five Prime Therapeutics announces changes to its board of directors

Nov 08, 2018: Oxford BioDynamics signs fifth collaboration agreement in immuno-oncology space

Nov 07, 2018: Five Prime Therapeutics announces third quarter 2018 financial results

Section 6 - Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Five Prime Therapeutics Inc, Performance Chart (2014 - 2018)

Five Prime Therapeutics Inc, Ratio Charts

Five Prime Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Five Prime Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Five Prime Therapeutics Inc, Key Facts

Five Prime Therapeutics Inc, Key Employees

Five Prime Therapeutics Inc, Key Employee Biographies

Five Prime Therapeutics Inc, Major Products and Services

Five Prime Therapeutics Inc, History

Five Prime Therapeutics Inc, Key Competitors

Five Prime Therapeutics Inc, Ratios based on current share price

Five Prime Therapeutics Inc, Annual Ratios

Five Prime Therapeutics Inc, Annual Ratios (Cont...1)

Five Prime Therapeutics Inc, Interim Ratios

Five Prime Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Five Prime Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Five Prime Therapeutics Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Five Prime Therapeutics Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Rexahn Pharmaceuticals Inc

Onconova Therapeutics Inc

Moleculin Biotech LLC

Fortress Biotech Inc

CytRx Corp

Five Prime Therapeutics Inc (FPRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description - A detailed description of the company's operations and business divisions.

- Corporate strategy - Analyst's summarization of the company's business strategy.

- SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history - Progression of key events associated with the company.

- Major products and services - A list of major products, services and brands of the company.

- Key competitors - A list of key competitors to the company.

- Key employees - A list of the key executives of the company.

- Executive biographies - A brief summary of the executives' employment history.

- Key operational heads - A list of personnel heading key departments/functions.

- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities - A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Five Prime Therapeutics Inc (Five Prime) is a clinical state biopharmaceutical company focusing on the research and development of novel treatments for cancer and inflammatory disorders. The company's developmental pipeline is based on the discovery platform and library of therapeutic proteins. The company's pipeline products include cabiralizumab; Bemarituzumab (FPA144); FPT155; FPA150; and BMS-986258. Five Prime has also developed proprietary protein screening technologies and rapid in vivo protein production system to identify new targets for protein therapeutics. The company has development collaborations with companies such as Bristol-Myers Squibb, GlaxoSmithKline, Zai Lab, Galaxy Biotech, BioWa-Lonza and UCB Pharma. Five Prime is headquartered in South San Francisco, California, the US.

Five Prime Therapeutics Inc Key Recent Developments

Jun 09,2019: Five Prime Therapeutics announces the departure of Dr. Sheila Gujrathi from its board of directors

May 15,2019: Five Prime Therapeutics names Carol Schafer to its board of directors

May 08,2019: Five Prime Therapeutics reports first quarter 2019 results

Mar 26,2019: Study shows Prime Therapeutics NetResults exclusion formulary doesn't lead to more medical use or higher costs

Feb 26,2019: Five Prime Therapeutics announces fourth quarter and full year 2018 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Five Prime Therapeutics Inc - Key Facts

Five Prime Therapeutics Inc - Key Employees

Five Prime Therapeutics Inc - Key Employee Biographies

Five Prime Therapeutics Inc - Major Products and Services

Five Prime Therapeutics Inc - History

Five Prime Therapeutics Inc - Company Statement

Five Prime Therapeutics Inc - Locations And Subsidiaries

Head Office

Section 2 - Company Analysis

Company Overview

Five Prime Therapeutics Inc - Business Description

Five Prime Therapeutics Inc - Corporate Strategy

Five Prime Therapeutics Inc - SWOT Analysis

SWOT Analysis - Overview

Five Prime Therapeutics Inc - Strengths

Five Prime Therapeutics Inc - Weaknesses

Five Prime Therapeutics Inc - Opportunities

Five Prime Therapeutics Inc - Threats

Five Prime Therapeutics Inc - Key Competitors

Section 3 - Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 - Company's Lifesciences Financial Deals and Alliances

Five Prime Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Five Prime Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Five Prime Therapeutics Inc, Recent Deals Summary

Section 5 - Company's Recent Developments

Jun 09, 2019: Five Prime Therapeutics announces the departure of Dr. Sheila Gujrathi from its board of directors

May 15, 2019: Five Prime Therapeutics names Carol Schafer to its board of directors

May 08, 2019: Five Prime Therapeutics reports first quarter 2019 results

Mar 26, 2019: Study shows Prime Therapeutics NetResults exclusion formulary doesn't lead to more medical use or higher costs

Feb 26, 2019: Five Prime Therapeutics announces fourth quarter and full year 2018 financial results

Jan 15, 2019: Five Prime announces restructuring to focus on clinical development and later-stage research priorities

Jan 09, 2019: Adimab provides 2018 update on clinical pipeline

Nov 29, 2018: Five Prime Therapeutics announces changes to its board of directors

Nov 08, 2018: Oxford BioDynamics signs fifth collaboration agreement in immuno-oncology space

Nov 07, 2018: Five Prime Therapeutics announces third quarter 2018 financial results

Section 6 - Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Five Prime Therapeutics Inc, Performance Chart (2014 - 2018)

Five Prime Therapeutics Inc, Ratio Charts

Five Prime Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Five Prime Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Five Prime Therapeutics Inc, Key Facts

Five Prime Therapeutics Inc, Key Employees

Five Prime Therapeutics Inc, Key Employee Biographies

Five Prime Therapeutics Inc, Major Products and Services

Five Prime Therapeutics Inc, History

Five Prime Therapeutics Inc, Key Competitors

Five Prime Therapeutics Inc, Ratios based on current share price

Five Prime Therapeutics Inc, Annual Ratios

Five Prime Therapeutics Inc, Annual Ratios (Cont...1)

Five Prime Therapeutics Inc, Interim Ratios

Five Prime Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Five Prime Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Five Prime Therapeutics Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Five Prime Therapeutics Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Rexahn Pharmaceuticals Inc

Onconova Therapeutics Inc

Moleculin Biotech LLC

Fortress Biotech Inc

CytRx Corp

chat_bubbleLet's Chat